Analysts at Jefferies give Roche and Prothena’s Phase III study just a 25% to 40% probability of success.
Roche, Prothena Push Parkinson’s Drug to Phase III Despite Mid-Stage Fail Read More »
The data released by a group of Democrat lawmakers found 338 rural hospitals were at risk of closure, conversion or service cutbacks if the reconciliation bill becomes law.
Hundreds of rural hospitals at risk if Medicaid cuts pass: Democrats Read More »
At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were also impressed by the tolerability profile.
Lilly Notches ‘Top-Tier’ Weight Loss Results for Phase I Amylin/Tirzepatide Combo Read More »
Analysts at Truist Securities called J&J’s CAR-T readout “compelling,” noting that the efficacy figures could position the cell therapy as a formidable competitor to the current standard of care, Gilead’s Yescarta.
J&J’s Dual-Targeting CAR T Hits 80% Complete Response in Early Lymphoma Study Read More »
Aunque el vals del Danubio Azul, compuesto por Johann Strauss hijo en 1866, está dedicado al río Danubio, la inclusión de esta pieza musical en la banda sonora de la legendaria película de ciencia-ficción “2001, una odisea del espacio” (1968), donde aco …
Transmiten al espacio profundo el vals del Danubio Azul Read More »
Stifel analysts said the deal “feels like an unremarkable outcome for a company that was once one of the hottest stories in CNS.” Supurnus’ offer beats Biogen’s unsolicited bid of about $7.22 per share, which arrived with a thud in late January.
Sage’s Story Comes to ‘Good End’ With Up To $795M Acquisition by Supurnus Read More »
Sarepta’s shares crashed 41% in pre-market trading Monday morning to $21.01 after the biotech reported a second death from acute liver failure, a known side effect of adeno-associated virus-based gene therapies.
Second Patient Dies After Receiving Sarepta’s DMD Gene Therapy Elevidys Read More »
According to an internal email, the agency may be in for more consolidation in areas including human resources, communications, travel and acquisitions.
Makary Considers More Cuts at FDA Amid Continued Delays Read More »
Hace más de una década que se cultivan organoides (pequeños grupos de células que reproducen la estructura básica de un órgano específico) para que sirvan como modelos biológicos en miniatura de tales órganos. Los organoides cerebrales s …
Avance clave hacia el cultivo de corazones, hígados y otros órganos Read More »
Cuando aumenta la carga de trabajo que realiza el corazón, se puede producir un aumento del grosor de la pared ventricular que se conoce como hipertrofia cardíaca. Se trata de una respuesta adaptativa que reduce la presión sobre el corazón y mantiene en buen estado la act …
Identifican un nuevo factor relacionado con la insuficiencia cardíaca Read More »
